1 Min Read
Sept 13 (Reuters) - 4SC AG:
* PHASE I STUDY OF 4SC‘S RESMINOSTAT INDICATES EFFICACY IN BILIARY TRACT CANCER Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.